Works matching IS 11707690 AND DT 1999 AND VI 16 AND IP 6
Results: 30
Salmeterol/fluticasone propionate combination product in asthma. An evaluation of its cost effectiveness vs fluticasone propionate.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 2
- Publication type:
- Article
Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma I: Introduction and Overview.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 1
- By:
- Publication type:
- Article
Cost-Effectiveness Analyses of Salmeterol/Fluticasone Propionate Combination Product and Fluticasone Propionate in Patients with Asthma II: Study Methodologies.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 9, doi. 10.2165/00019053-199916002-00002
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/100µg vs Fluticasone Propionate 100µg in Adults and Adolescents with Asthma III: Results.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 15, doi. 10.2165/00019053-199916002-00003
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/250µg vs Fluticasone Propionate 250µg in Adults and Adolescents with Asthma IV: Results.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 23, doi. 10.2165/00019053-199916002-00004
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500µg vs Fluticasone Propionate 500µg in Patients with Corticosteroid-Dependent Asthma V: Results.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 29, doi. 10.2165/00019053-199916002-00005
- By:
- Publication type:
- Article
A Pharmacoeconomic Model for the Treatment of Influenza.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 73, doi. 10.2165/00019053-199916001-00010
- By:
- Publication type:
- Article
Cochrane Reviews and Systematic Reviews of Economic Evaluations: Amantadine and Rimantadine in the Prevention and Treatment of Influenza.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 85, doi. 10.2165/00019053-199916001-00011
- By:
- Publication type:
- Article
Workshop 1: Appraising the Methods for Economic Evaluation.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 91, doi. 10.2165/00019053-199916001-00012
- By:
- Publication type:
- Article
Workshop 2: The Needs of Policy-Makers.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 94, doi. 10.2165/00019053-199916001-00013
- By:
- Publication type:
- Article
Workshop 3: Antivirals and Vaccination for Influenza.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 97, doi. 10.2165/00019053-199916001-00014
- By:
- Publication type:
- Article
Individual and Community Impact of Influenza.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 1, doi. 10.2165/00019053-199916001-00001
- By:
- Publication type:
- Article
Communication of Socioeconomic Research Findings.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 7, doi. 10.2165/00019053-199916001-00002
- By:
- Publication type:
- Article
Socioeconomic Evaluation in Medicine in Europe: Core Economic Concepts.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 19, doi. 10.2165/00019053-199916001-00003
- By:
- Publication type:
- Article
Influenza: The Role of Burden-of-Illness Research.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 27
- By:
- Publication type:
- Article
Economic Evaluation of Influenza Vaccination: Assessment for The Netherlands.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 33, doi. 10.2165/00019053-199916001-00005
- By:
- Publication type:
- Article
Measures for Control of Influenza.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 41, doi. 10.2165/00019053-199916001-00006
- By:
- Publication type:
- Article
Influenza Vaccination in 29 Countries: An Update to 1997.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 47, doi. 10.2165/00019053-199916001-00007
- By:
- Publication type:
- Article
Willingness to Pay and the Valuation of Programmes for the Prevention and Control of Influenza.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 55, doi. 10.2165/00019053-199916001-00008
- By:
- Publication type:
- Article
The Health and Economic Benefits of Influenza Vaccination for Healthy and At-Risk Persons Aged 65 to 74 Years.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 63, doi. 10.2165/00019053-199916001-00009
- By:
- Publication type:
- Article
Acamprosate. Pharmacoeconomic implications of therapy.
- Published in:
- 1999
- By:
- Publication type:
- journal article
The doctor-patient relationship and prescribing patterns. A view from primary care.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Measuring Quality of Life in Paediatric Patients.
- Published in:
- PharmacoEconomics, 1999, v. 16, n. 6, p. 605, doi. 10.2165/00019053-199916060-00002
- By:
- Publication type:
- Article
Diagnosis and management of osteomyelitis. Decision analytic and pharmacoeconomic considerations.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Managing pharmaceutical expenditure while increasing access. The pharmaceutical management agency (PHARMAC) experience.
- Published in:
- 1999
- By:
- Publication type:
- journal article
The effect of generic competition on prescription to over-the-counter switching.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Health economics in the Canadian pharmaceutical industry.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Economic evaluation of long-term management strategies for erosive oesophagitis.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Annual cost of erectile dysfunction to UK Society.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Abciximab. A pharmacoeconomic review of its use in percutaneous coronary revascularisation.
- Published in:
- 1999
- By:
- Publication type:
- journal article